1. 580 Percutaneous coronary intervention or medical therapy as initial management strategy of patients with spontaneous coronary artery dissections: insight from the multicentre, international dissezioni spontanee coronariche (disco) registry. (8th December 2021) Authors: Benenati, Stefano; Giacobbe, Federico; Zingarelli, Antonio; Alessandra, Truffa Giachet; Lombardi, Primiano; Musumeci, Giuseppe; Cinconze, Sebastian; Barbero, Umberto; Iannaccone, Mario; Patti, Giuseppe; Rognoni, Antonio; Menunni, Marco; Di Leo, Angelo; Infantino, Vincenzo; Gambino, Alfonso; D'Asc... Journal: European heart journal supplements Issue: Volume 23(2021)Supplement G Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2− advanced breast cancer. Issue 2 (February 2015) Authors: Jerusalem, Guy; Bachelot, Thomas; Barrios, Carlos; Neven, Patrick; Di Leo, Angelo; Janni, Wolfgang; de Boer, Richard Journal: Cancer treatment reviews Issue: Volume 41:Issue 2(2015) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). (December 2019) Authors: Risi, Emanuela; Biagioni, Chiara; Benelli, Matteo; Migliaccio, Ilenia; McCartney, Amelia; Bonechi, Martina; Guarducci, Cristina; Hilbers, Florentine; Di Cosimo, Serena; Huober, Jens; Romagnoli, Dario; Boccalini, Giulia; Vitale, Stefania; Sotiriou, Christos; Biganzoli, Laura; Di Leo, Angelo; Malor... Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Issue 3 (March 2022) Authors: Bradley, Rosie; Braybrooke, Jeremy; Gray, Richard; Hills, Robert K; Liu, Zulian; Pan, Hongchao; Peto, Richard; Dodwell, David; McGale, Paul; Taylor, Carolyn; Francis, Prudence A; Gnant, Michael; Perrone, Francesco; Regan, Meredith M; Berry, Richard; Boddington, Clare; Clarke, Mike; Davies, Christ... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98†. Issue 2 (29th August 2013) Authors: Senkus, Elżbieta; Gomez, Henry; Dirix, Luc; Jerusalem, Guy; Murray, Elizabeth; Van Tienhoven, Geertjan; Westenberg, A. Helen; Bottomley, Andrew; Rapion, Jérôme; Bogaerts, Jan; Di Leo, Angelo; Nešković‐Konstantinović, Zora Journal: Psycho-oncology Issue: Volume 23:Issue 2(2014) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Issue 10 (October 2018) Authors: Galimberti, Viviana; Cole, Bernard F; Viale, Giuseppe; Veronesi, Paolo; Vicini, Elisa; Intra, Mattia; Mazzarol, Giovanni; Massarut, Samuele; Zgajnar, Janez; Taffurelli, Mario; Littlejohn, David; Knauer, Michael; Tondini, Carlo; Di Leo, Angelo; Colleoni, Marco; Regan, Meredith M; Coates, Alan S; G... Journal: Lancet oncology Issue: Volume 19:Issue 10(2018) Page Start: 1385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018) Authors: Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lønning, Per E; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel; Csőszi, Tibor; Bordonaro, Roberto; Decker, Thomas; Tjan-Heijnen, Vivianne C G; Blau, Sibel; Schirone, Alessio; Weber, Denis; ... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE). (15th January 2021) Authors: Quadri, Giorgio; Rognoni, Andrea; Cerrato, Enrico; Baralis, Giorgio; Boccuzzi, Giacomo; Brscic, Elvis; Conrotto, Federico; De Benedictis, Michele; De Martino, Leonardo; Di Leo, Angelo; Ferrari, Fabio; Gagnor, Andrea; Greco Lucchina, Giuseppe Pietro; Montaldo, Tiziana; Patti, Giuseppe; Gribaudo, E... Journal: International journal of cardiology Issue: Volume 323(2021) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer. (February 2021) Authors: Migliaccio, Ilenia; Bonechi, Martina; McCartney, Amelia; Guarducci, Cristina; Benelli, Matteo; Biganzoli, Laura; Di Leo, Angelo; Malorni, Luca Journal: Cancer treatment reviews Issue: Volume 93(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update. Issue 35 (10th December 2021) Authors: Moy, Beverly; Rumble, R. Bryan; Come, Steven E.; Davidson, Nancy E.; Di Leo, Angelo; Gralow, Julie R.; Hortobagyi, Gabriel N.; Yee, Douglas; Smith, Ian E.; Chavez-MacGregor, Mariana; Nanda, Rita; McArthur, Heather L.; Spring, Laura; Reeder-Hayes, Katherine E.; Ruddy, Kathryn J.; Unger, Paul S.; V... Journal: Journal of clinical oncology Issue: Volume 39:Issue 35(2021) Page Start: 3938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗